攜程集團-S(9961.HK)低開5.85% Q4營收環比下滑
格隆匯3月8日丨港股攜程低開5.85%報296港元;隔夜港股攜程收跌2.8%報37.53美元,折算成港股市場價格為295.3港元/股。公司週二(3月7日)盤後公佈業績顯示,Q4營收50.3億元人民幣,同比增長7.5%,環比下降27%;淨利潤為20.8億元人民幣,相比2021年同期淨虧損8.83億元人民幣,環比增長7.49倍。公吿稱,營業收入環比下降主要由於中國局部地區新冠疫情反覆以及季節性的影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.